Neck Dissection Via a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynx
RoboCurage ORL
Unilateral Selective Neck Dissection at Lymph Node Levels IIa, III and IV Using a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynx: the First Three Patients
2 other identifiers
interventional
3
1 country
1
Brief Summary
The main hypothesis of this study is that it is possible to make a unilateral selective dissection of ganglion levels IIa, III and IV using an endoscopic transaxillary approach via the da Vinci robotic system to reduce scarring, while respecting patient safety. Feasibility will be assessed by two combinded criteria: 1) performance of the surgical procedure respecting the different stages of visualization and dissection of key anatomical elements; 2) obtain a minimum of 9 lymph nodes when analyzing pathological evidence of the dissection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Feb 2015
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 8, 2014
CompletedFirst Posted
Study publicly available on registry
October 20, 2014
CompletedStudy Start
First participant enrolled
February 16, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 4, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 14, 2017
CompletedJanuary 11, 2019
January 1, 2019
2.6 years
October 8, 2014
January 10, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of patients that had pre-defined key points of the surgical procedure performed
Were all pre-defined key points of the surgical procedure performed? yes/no Description of the key points (includes (i) axillary approach, (ii) robot arm insertion, (iii) dissection, (iv) closing) of the surgical procedure.
Day 0
Number of lymph nodes dissected
Determined by analysis of excised tissues.
Day 0
Secondary Outcomes (12)
The duration of surgical site preparation
Day 0
The duration of robot installation / preparation
Day O
Intervention time (between incision and closure by the surgeon)
Day 0
Time in general anesthesia
Day 0
Surgical time (console time for robot-assisted surgery)
Day 0
- +7 more secondary outcomes
Other Outcomes (41)
The number of ganglions excised at each level.
expected between day 7 and day 15
The number of metastatic ganglions
expected between day 7 and day 15
The presence/absence of capsular rupture
expected between day 7 and day 15
- +38 more other outcomes
Study Arms (1)
3 patients cancer of the epi larynx
EXPERIMENTAL3 patients with squamous cell carcinoma of the epi-larynx Intervention: Neck Dissection
Interventions
Unilateral Selective Neck Dissection at Lymph Node Levels IIa, III and IV Using a Robot-assisted Transaxillary Approach. The robotic system used is the da Vinci system.
Eligibility Criteria
You may qualify if:
- Cancer of the epi-larynx: (i) ranked T1 or T2 in the TNM classification, (ii) supraglottic or glotto-supraglottic location, (iii) CN0 nodal status
- Absence of distant metastasis (M0)
- Decision for unilateral endoscopic axillary neck dissection at lymph node levels IIa, III and IV of the Robins classification is retained in a multidisciplinary meeting
- The patient is available for 12 months of follow-up
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
You may not qualify if:
- Adult under judicial protection or any kind of guardianship
- Refusal to sign the consent
- It is impossible to correctly inform the patient
- The patient is pregnant, parturient, or breastfeeding
- Preoperative diagnosis of a second location of cancerous disease
- Body Mass Index \> 25
- History of cervical spine surgery
- History of instability of the cervical spine
- History of surgery in the shoulder or pre-pectoral region
- History of ipsilateral neck surgery
- History of cervical radiotherapy
- History of breast implants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin Lallemant, MD, PhD
Centre Hospitalier Universitaire de Nîmes
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 8, 2014
First Posted
October 20, 2014
Study Start
February 16, 2015
Primary Completion
September 4, 2017
Study Completion
September 14, 2017
Last Updated
January 11, 2019
Record last verified: 2019-01